Oncidium foundation

Exciting times ahead at #EANM24 in Hamburg, Germany! Join our team at Hall H, Booth H35. We’ve prepared something special for you: 📅 Friday, October 18 at 6 PM: The Tackle Cancer Challenge kicks off at Planten & Blomen Park. Two routes are available: 2 KM and 5 KM – bring your energy and join us for a great cause! 🌅 Daily Morning Run/Walk – October 19th, 20th, 21st, 22nd – 6:45 AM #TCChallenge2024 - More information here: https://buff.ly/3o2EI9B 🎤 Sunday, October 20 at 16:45 (Hall G1): Don’t miss our CEO, Rebecca Lo bue, as she presents on the Scope and Impact of Foundations in Nuclear Medicine – real-life examples of how we are driving change in patient care. Looking forward to seeing you there! 👋 #Radiotheranostics #RadioligandTherapy #CancerCare #OncidiumFoundation

This morning, we had the privilege of supporting and participating in an inspiring patient session at Itanet Associaz. italiana tumori Neuroendocrini in Palermo. A key takeaway from the discussion was the critical need for an integrated, multidisciplinary care approach, especially during the diagnosis phase. The importance of patient associations was also emphasized—NET Italy ETS , in particular, is making a real difference in the journey of NET patients in Italy through its close connection with those it supports. Huge thanks to Chiara Maria Grana and the organizing committee for bringing and listening to the voice of patients at such an important conference. #Neuroendocrinetumor

📣 The Oncidium Foundation Expands to the U.S. During Nuclear Medicine and Molecular Imaging Week! As we celebrate Nuclear Medicine and Molecular Imaging Week, we're very happy to announce that the Oncidium foundation now has an official U.S. subsidiary! This milestone strengthens our mission to make hashtag #RadioligandTherapy (RLT) more accessible to people living with cancer in the U.S. and around the world. Our U.S. dedicated ambassador, Jean-Luc Vanderheyden, shared his enthusiasm: “I have been in the field of nuclear medicine for nearly 44 years. It's exciting to see the progress made, particularly the potential radiotheranostics has to treat patients who previously had little hope. I am eager to bring education, hope, and new treatment possibilities to patients in the U.S., and that’s what motivates me.” In line with this week’s celebration of advancements in nuclear medicine and molecular imaging, we are proud to continue driving innovation in cancer care and raising awareness for RLT as a life-changing treatment option. Learn more: https://buff.ly/4h1eX0E #Oncidiumfoundation #RadioligandTherapy #CancerCare #HealthcareInnovation #PatientCare #NuclearMedicineWeek #MolecularImaging #USA

Sta accadendo: https://buff.ly/4eZdnKT Connettetevi ora per vedere il nostro CEO che parla 😊

Announcing the launch of the Thera4Care project - Theranostics Ecosystem For Personalised Care! This public-private initiative aims to revolutionise precision oncology and establish Europe as a global leader in theranostics. Theranostics combines diagnostic tests with targeted therapies, enabling personalised treatments. By binding molecules with radioactive isotopes to specific proteins on cancer cells, the disease can be diagnosed and treated with precision. Thera4Care brings together academic centres, healthcare providers, SMEs, and industry stakeholders to create a collaborative European ecosystem to support healthcare system readiness for theranostics. We aim to: • 🔬 Strengthen the manufacturing and supply chain of radiotheranostics. • 🧪 Develop advanced cancer models to test these therapies in the lab. • 📊 Create a framework for phase 1 clinical trials. • 🤖 Enhance clinical outcomes through AI-based imaging and personalized dosing protocols. For more information, check our website: www.thera4care.eu Thera4Care is funded by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172788. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, Atley Solutions, Curasight, Dosisoft, Minerva Imaging, Perspective Therapeutics, and Terthera. Evis Sala Salvatore Annunziata Ben Newton Ken Herrmann #Thera4Care #IHI #PrecisionOncology #Theranostics #HealthcareInnovation

The Oncidium foundation is honored to be involved in the Thera4Care project - a pioneering initiative focused on advancing precision oncology and theranostics in Europe. In collaboration with academic centers, healthcare providers, SMEs, and industry stakeholders, we are dedicated to building a cooperative ecosystem for personalized cancer care, all in a mission to revolutionize cancer treatment and improve lives. Learn more 👉 https://lnkd.in/eRKdExVU #Thera4Care #IHI #PrecisionOncology #Theranostics #HealthcareInnovation #radiotheranostics

💻 Collegatevi online domani, Giovedì 10 ottobre alle 10:00 AM: https://buff.ly/4eZdnKT La fondazione Oncidium è lieta di supportare la sessione dedicata ai pazienti durante l'XI Congresso Nazionale ITANET a Palermo. Questa occasione permetterà di condividere il percorso delle persone affette da tumori neuroendocrini che hanno avuto accesso alla terapia con radioligandi. I pazienti presenti o collegati online avranno inoltre l'opportunità di porre domande agli esperti presenti. 👩⚕️ Professionisti del settore sanitario: vi invitiamo a condividere questa opportunità unica con i vostri pazienti! 🗣 Nota: la sessione sarà tenuta in italiano. #ITANET #CancerCare #RadioligandTherapy #OncidiumFoundation #PatientCare #Italy

We are very happy to welcome Dr. Nii Boye Hammond as our new ambassador in Accra, Ghana. As one of the few nuclear medicine physicians in Ghana, he is passionate about advancing the field of nuclear medicine. Aligned with the Oncidium foundation's mission, he is advocating for #radiotheranostics, focusing on education for both patients and healthcare professionals to improve #patientaccess in Ghana and beyond! Welcome on board, Dr. Hammond ! 🤗 Learn more about our Ambassadors worldwide 🌍 https://buff.ly/3xCf28K #nuclearmedicine #theranostics #OncidiumAmbassadors #workingbeyondborders

🚨 The Oncidium foundation is looking for a Regional Partnership Manager based in Belgium to join our team! In this role, you will develop and manage partnerships with nuclear medicine and radiopharmaceutical experts, work closely with our team of Ambassadors to expand access to radioligand therapy (RLT) around the world, represent the foundation at international events, and drive meaningful innovations in cancer care. Strong English communication skills and expertise in the nuclear medicine/RLT field are essential, as we operate globally. Read more here: https://buff.ly/4eyJjWr 🌟 If you’re passionate about making a real difference in cancer care, we encourage you to apply by sending your CV to contact@oncidium-life.org by November 3rd, 2024. #JobOpening #CancerCare #Oncidiumfoundation

The Tackle Cancer Challenge is just two weeks away! Register now 👉 https://buff.ly/3o2EI9B Our goal is to cover 50,000 km together! No matter what your sporting activity is—whether you're running, swimming, climbing, gardening, or practicing yoga—every effort helps raise awareness about #Radiotheranostics for #CancerCare worldwide. SPECIAL INVITATION for all @EANM participants 🤩: Join us for the official running/walking launch of the Tackle Cancer Challenge, with 2 km and 5 km route options! 📆 October 18th at 6 p.m. 🚩 Planten & Bloemen Park, right next to the Congress Center Hamburg. Sportswear is highly recommended! 😁 #TCChallenge2024 #Oncidiumfoundation #TackleCancerChallenge #Awareness #EANM2024